[Interventional studies on acute-on-chronic liver failure: challenges and opportunities].

Acute-on-chronic liver failure (ACLF) is a kind of complex syndrome characterized by acute deterioration of liver function on the basis of chronic liver disease, accompanied by organ failure and a high mortality rate. The International Society for Hepatology has proposed different definitions, diagnostic criteria, and treatment guidelines, which have led to differences in the clinical management of ACLF and underestimated the burden of the disease. Currently, there is no specific treatment for ACLF, and the overall prognosis is still not ideal. This article profoundly explores the problems existing in the interventional studies of ACLF and provides a new perspective for in-depth research on the pathogenesis and progression, the development of new intervention measures, the promotion of personalized treatment, and the formulation of more accurate diagnostic criteria and risk prediction models.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2024-12-20
DOI
https://doi.org/10.3760/cma.j.cn501113-20240902-00465
Primary Topic
Drug-Induced Hepatotoxicity and Protection
Type
article
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[Interventional studies on acute-on-chronic liver failure: challenges and opportunities].

Pengfei Yu, Mengting Xu, Yu Chen
PubMed
Drug-Induced Hepatotoxicity and Protection
article

[Interventional studies on acute-on-chronic liver failure: challenges and opportunities].

Pengfei Yu, Mengting Xu, Yu Chen
article en

Abstract

Acute-on-chronic liver failure (ACLF) is a kind of complex syndrome characterized by acute deterioration of liver function on the basis of chronic liver disease, accompanied by organ failure and a high mortality rate. The International Society for Hepatology has proposed different definitions, diagnostic criteria, and treatment guidelines, which have led to differences in the clinical management of ACLF and underestimated the burden of the disease. Currently, there is no specific treatment for ACLF, and the overall prognosis is still not ideal. This article profoundly explores the problems existing in the interventional studies of ACLF and provides a new perspective for in-depth research on the pathogenesis and progression, the development of new intervention measures, the promotion of personalized treatment, and the formulation of more accurate diagnostic criteria and risk prediction models.

PubMedVol. 32(12)
Beijing Academy of Artificial Intelligence (CN), 302 Military Hospital of China (CN), Beijing YouAn Hospital (CN)
Drug-Induced Hepatotoxicity and Protection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.